PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 29 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,031 | -21.8% | 621,100 | -5.8% | 0.00% | 0.0% |
| Q2 2023 | $1,319 | -48.1% | 659,300 | -45.5% | 0.00% | -33.3% |
| Q1 2023 | $2,540 | +724.7% | 1,209,750 | +438.6% | 0.00% | – |
| Q4 2022 | $308 | -99.7% | 224,603 | +91.6% | 0.00% | – |
| Q3 2022 | $122,000 | -2.4% | 117,200 | +2.1% | 0.00% | – |
| Q2 2022 | $125,000 | +861.5% | 114,800 | +864.7% | 0.00% | – |
| Q1 2022 | $13,000 | -77.2% | 11,900 | -60.4% | 0.00% | – |
| Q2 2021 | $57,000 | -97.5% | 30,075 | -94.1% | 0.00% | -100.0% |
| Q1 2021 | $2,264,000 | +27.6% | 507,634 | +3.9% | 0.00% | +50.0% |
| Q4 2020 | $1,774,000 | -6.5% | 488,634 | -0.3% | 0.00% | 0.0% |
| Q3 2020 | $1,898,000 | -5.6% | 490,334 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $2,010,000 | +79.1% | 530,434 | +11.1% | 0.00% | +100.0% |
| Q1 2020 | $1,122,000 | -25.6% | 477,434 | +3.9% | 0.00% | 0.0% |
| Q4 2019 | $1,508,000 | – | 459,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |